Personalized Fibrocartilage Implant Fabrication System with AI, IoT, and Blockchain Integration

Publication ID: 24-11857425_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Personalized Fibrocartilage Implant Fabrication System with AI, IoT, and Blockchain Integration,” Published Technical Disclosure No. 24-11857425_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857425_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,425.

Summary of the Inventive Concept

A novel system that integrates AI, IoT, and blockchain technologies to create personalized fibrocartilage implants, offering enhanced precision, security, and real-time monitoring capabilities.

Background and Problem Solved

The original patent disclosed a system and method for making personalized fibrocartilage implants. However, it lacked the ability to securely manage patient data, optimize implant geometries, and provide real-time monitoring. The new inventive concept addresses these limitations by incorporating AI, IoT, and blockchain technologies to create a more comprehensive and effective system.

Detailed Description of the Inventive Concept

The system comprises a blockchain-based data storage module for secure patient data management, an AI-powered design module for generating optimized implant geometries based on patient-specific data, and a 3D printing module for fabricating the implant with integrated IoT sensors for real-time monitoring. The system may also include a wearable device for collecting patient-specific biomechanical data, a decentralized AI-powered design network for generating optimized implant geometries, and a hybrid 3D printing-robotic assembly module for fabricating the implant with integrated IoT sensors. The system enables secure collaboration with multiple stakeholders, integrates AI-powered design optimization with IoT-enabled real-time monitoring, and fabricates the implant using a novel combination of 3D printing and robotic assembly techniques.

Novelty and Inventive Step

The new inventive concept introduces the integration of AI, IoT, and blockchain technologies to create a personalized fibrocartilage implant fabrication system, which is not disclosed in the original patent. The inventive step lies in the synergistic combination of these technologies to provide enhanced precision, security, and real-time monitoring capabilities.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, IoT sensor configurations, or blockchain protocols. Variations may include the integration of additional technologies, such as machine learning algorithms or novel biomaterials, to further enhance the system's capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the orthopedic and biomedical industries, offering a novel solution for personalized fibrocartilage implant fabrication. The system's enhanced precision, security, and real-time monitoring capabilities make it an attractive solution for hospitals, clinics, and medical research institutions.

CPC Classifications

SectionClassGroup
A A61 A61F2/3872
A A61 A61B34/10
A A61 A61F2/30942
A A61 A61F2/442
A A61 A61B2034/102
A A61 A61F2002/302
A A61 A61F2002/30069
A A61 A61F2002/30952
A A61 A61F2002/4495

Field of Art

Biomedical engineering, specifically tissue engineering and personalized medical device fabrication, focusing on orthopedic implant design and advanced manufacturing techniques

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer with expertise in 3D printing, tissue engineering, medical device design, and advanced manufacturing technologies, holding a master's or PhD with 3-5 years of specialized experience in personalized medical implant development

Obviousness Rationale

A PHOSITA would recognize that integrating emerging technologies like AI, IoT, and blockchain into the existing personalized fibrocartilage implant fabrication process represents a predictable evolution of the source patent's core methodology. The fundamental approach of creating patient-specific implants remains consistent, with the PTD merely introducing additional technological layers for enhanced design, monitoring, and data management. These technological integrations represent well-known techniques in advanced medical device manufacturing that would be obvious to apply to the existing personalized implant fabrication process.

Obvious Combinations & Variations

Source Patent Element
Personalized implant fabrication using patient-specific tissue dimension data and weighting factors
PTD Variation
AI-powered design module generating optimized implant geometries based on patient-specific data
Obviousness Reasoning
Using machine learning and AI to optimize design parameters is a predictable application of computational techniques to existing personalized manufacturing processes, representing an obvious design improvement
Source Patent Element
Weaving machine forming interlaced fibrous structure for implant
PTD Variation
Hybrid 3D printing-robotic assembly module for fabricating implant with integrated IoT sensors
Obviousness Reasoning
Extending manufacturing techniques to incorporate sensor integration and advanced fabrication methods is a known approach in medical device development, representing an obvious technological progression
Source Patent Element
Implant fabrication process involving scaffold material and tissue-specific dimensions
PTD Variation
Blockchain-based data storage and supply chain management for secure patient data and material tracking
Obviousness Reasoning
Implementing secure data management and tracking technologies is a predictable solution for improving medical device development processes, representing an obvious enhancement to existing manufacturing methodologies
Source Patent Element
Personalized implant design based on tissue dimensions
PTD Variation
Wearable device collecting patient-specific biomechanical data for implant design optimization
Obviousness Reasoning
Expanding data collection methods to improve personalization is a logical and obvious extension of existing patient-specific design approaches in medical device development
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857425 and the disclosed technological variations, a person of ordinary skill in the art would find the proposed personalized fibrocartilage implant fabrication system with integrated AI, IoT, and blockchain technologies to be an obvious combination of known techniques in medical device manufacturing, rendering potential claims to such a system obvious and unpatentable under 35 U.S.C. Section 103.

Original Patent Information

Patent NumberUS 11,857,425
TitleSystem and method for making personalized fibrocartilage implants
Assignee(s)Rutgers, The State University of New Jersey